Cancer Treatment and Research Communications
Publisher: Elsevier · ISSN 2468-2942 · 88 articles
- Lack of a systematic approach and unified standards in frailty assessment among patients with gastric cancer: a scoping review
- Multimodal AI for early lung cancer detection: from LDCT to clinical and molecular integration
- Organ-specific liquid biopsy in lung cancer: the emerging role of exhaled breath condensate
- Non-coding RNAs as mediators of tyrosine kinase inhibitor resistance in chronic myeloid leukemia: a scoping review
- Cancer-associated fibroblasts during and after therapy: disentangling state, function and persistence
- Rediscovering Kaposi Sarcoma in North Africa: Thirteen years of HIV-negative cases and survival insights from Morocco
- Rethinking cardiovascular risk stratification in TKI-treated chronic myeloid leukemia
- Hereditary cancer syndromes as a model for precision oncology: the paradigms of HRD and MSI
- Elevated expression of olfactory receptor 51T1 is associated with malignant potential of bladder cancer
- Pleural metastasis of bone and soft tissue sarcomas: A review
- Impact of primary tumor location on survival outcomes and recurrence patterns in patients with stage III non-small cell lung cancer: A retrospective observational study
- Pretreatment lactate dehydrogenase, but not magnesium or neutrophil-to-lymphocyte ratio, is independently associated with grade ≥3 chemotherapy toxicity in breast cancer: prediction-model development and internal validation in 400 patients
- Global, G20, and China burden of malignant neoplasms of bone and articular cartilage from 1990 to 2050: trends, projections, and ecological associations with healthcare expenditure
- Association of neoadjuvant radiotherapy with 10-year survival outcomes in large cell lung cancer: A retrospective SEER-based study
- Prognostic impact of residual viable tumor percentage on non-small cell lung cancer recurrence after neoadjuvant immunochemotherapy
- Diagnostic value of Node-RADS in predicting lymph node metastasis in endometrial cancer
- The prognostic value of HER2 in gastroesophageal adenocarcinoma – a meta-analysis
- Drastic muscle wasting following surgery is a strong predictor of prognosis in early-stage pancreatic cancer–a Taiwanese multicenter cohort study
- Increased abdominal visceral adipose tissue (VAT) in patients with metastatic lung adenocarcinoma under ALK inhibitors is associated with prolonged progression-free survival
- Unmet Needs, Quality of Life, and Lived Experiences of Patients with Metastatic Breast Cancer in Central Vietnam: A Convergent Mixed-Methods Study
- Prognostic implications of asymptomatic COVID-19 infection in non-small-cell lung cancer patients receiving active anticancer treatment: an observational study with prospective survival follow-up
- Immunotherapy and circulating tumor DNA in HPV-positive oropharyngeal cancer: a systematic review and exploratory meta-analysis of survival and surveillance outcomes
- Female breast and gynecological cancers in Asia, 1990–2021: Burden and trends from the global burden of disease study
- CAD potentially mediates 5‑fluorouracil resistance in gastric cancer cells via modulation of uridine monophosphate synthetase expression
- Emerging immunotherapies in melanoma beyond immune checkpoint inhibitors: Vaccines, intralesional therapies, adoptive cell therapies, and T-cell engagers
- Age-related early mortality and competing-risk outcomes in angioimmunoblastic T-cell lymphoma: a SEER-based population study
- Effect of electromagnetic waves from doxorubicin on breast cancer growth in a mouse model
- Microbiota modulation in colorectal cancer: A scoping review of its potential role in toxicity mitigation and treatment response
- Solasodine-derived steroidal alkaloids as dual modulators of PI3K/Akt signaling and metabolic reprogramming in breast cancer
- Interpretable CT-based radiomics nomogram integrating clinical and semantic features for preoperative grading of pancreatic neuroendocrine neoplasms: a shap-based analysis